Literature DB >> 5934250

On the clinical evaluation of diuretics with particular reference to a new phthalimidine diuretic, clorexolone.

A F Lant, W I Baba, G M Wilson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5934250     DOI: 10.1002/cpt196672196

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  7 in total

Review 1.  Diuretics: mechanism of action and clinical application.

Authors:  D L Davies; G M Wilson
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Bioassay of aldosterone antagonists in normal human subjects: a relationship between the level of plasma uric acid before treatment and apparent drug responses.

Authors:  L E Ramsay; P Hessian; M J Tidd
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

Review 3.  Diuretics. Clinical pharmacology and therapeutic use (Part I).

Authors:  A Lant
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

4.  Renal actions of a uricosuric diuretic, racemic indacrinone, in man: comparison with ethacrynic acid and hydrochlorothiazide.

Authors:  B A Brooks; A F Lant; W R McNabb; F H Noormohamed
Journal:  Br J Clin Pharmacol       Date:  1984-05       Impact factor: 4.335

5.  Antagonism of endogenous mineralocorticoids in normal subjects by prorenoate potassium and spironolactone.

Authors:  D Levine; L Ramsay; R Auty; R Branch; M Tidd
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

6.  Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects.

Authors:  C J Roberts; M Homeida; F Roberts; W Bogie
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

7.  A single dose comparison of piretanide and bumetanide in congestive cardiac failure.

Authors:  M Homeida; C J Roberts; S L Dombey
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.